PTGS1 Genetic Variation and Increased Risk for Persistent Pulmonary Hypertension of the Newborn
Medical College of Wisconsin · NCT00710177
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Up to age 1 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 200
- US sites recruiting
- 1
- Study start
- January 2006
- Record last updated
- January 26, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The purpose of this study is to determine if normally occurring variations in a specific gene called PTGS-1 are associated with an increased risk of narrowing of the ductus arteriosus from exposure to over-the-counter pain medicines (NSAIDs).
Conditions: Persistent Pulmonary Hypertension of the Newborn
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Infants born greater than or equal to 34 weeks gestational age diagnosed with PPHN and normal, healthy infants born greater than or equal to 34 weeks gestational age.
Exclusion Criteria
- Patients will be excluded if they are diagnosed with lethal congenital anomalies
- structural congenital heart disease except presence of patent ductus arteriosus (PDA) or patent foramen ovale
- structural gastrointestinal tract abnormality that could interfere with meconium passage
- congenital anomalies such as diaphragmatic hernia, Potter's syndrome, or pulmonary hypoplasia
Recruiting US locations
Children's Wisconsin
Milwaukee, WI 53226
Site contact: Ganesh Konduri, MD
Study contacts (from the official record)
- G. Ganesh Konduri, MD · 414-266-6820 · gkonduri@mcw.edu
- Kathleen M Meskin, BSN · 414-337-7171 · kmeskin@mcw.edu
Similar studies in Wisconsin
All heart & blood pressure studies in Wisconsin →- RecruitingHealthy volunteers
BoxX-NoAF Clinical Trial
AtriCure, Inc.
- Location
- Wausau, WI + 30 other US sites
- Eligibility basics
- Ages 65+
- Recruiting
Virtue® SAB in the Treatment of Coronary ISR Trial
Orchestra BioMed, Inc
- Location
- Milwaukee, WI + 21 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Prevail Global Study
Medtronic Vascular
- Location
- La Crosse, WI + 53 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Failure
CVRx, Inc.
- Location
- Marshfield, WI + 16 other US sites
- Eligibility basics
- Ages 18+